|
|
|
|
Measuring Patient Views of HIV Treatments:
Comparing Dolutegravir With Darunavir/r in the FLAMINGO Study
|
|
|
Reported by Jules Levin
20th International AIDS Conference; July 20-25, 2014; Melbourne, Australia
Murray M,1 Goodwin B,2 Hagins D,3 Gallien S,4 Brennan C,2 Min S2
1ViiV Healthcare, London, UK; 2GlaxoSmithKline, Research Triangle Park, NC, USA; 3Chatham County Health Department, Savannah, GA, USA; 4H™pital Saint Louis, Paris, France
|
|
|
|
|
|
|